Wed, 4 Nov
Ended
Earnings calls
Dr. Lal Pathlabs concalls
Every Dr. Lal Pathlabs earnings call we streamed: the live audio and our summary of what management said.
Calls
Earlier call summaries
All →
18:08 IST
NSE
Earnings Call
Dr. Lal Pathlabs Earnings Call: Key Takeaways
Dr. Lal PathLabs reported strong Q4 FY26 results with 16.6% revenue growth. Focus remains on expansion through 1,100+ new collection centers and high-end diagnostic branding.
16:10 IST
BSE
Earnings Call
Dr. Lal Pathlabs Earnings Call: Key Takeaways
Dr. Lal PathLabs reported strong Q4 FY26 revenue growth of 16.6% YoY, driven by volume momentum. The company is focusing on digital transformation and expanding into Tier 3+ markets.
16:09 IST
NSE
Earnings Call
Dr. Lal Pathlabs Earnings Call: Key Takeaways
Dr. Lal PathLabs delivered steady growth in Q4 FY26, with revenue rising 16.6% YoY to ₹703 cr. Performance was driven by high sample volumes and expansion into Tier 3+ markets.
Dr. Lal Pathlabs Ltd: key numbers
- Share price
- ₹2,045.00
- Market cap
- ₹34,325 Cr
- Revenue (annual)
- ₹2,763 Cr
- Net profit (annual)
- ₹504.8 Cr
- P/E (TTM)
- 58.8×Sector 53.8×
- Promoter holding
- 52.93%-0.26% QoQ
- FII holding
- 18.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.